Where Do I Put My Wegovy Shot? A Guide to Proper Injection Sites and Technique

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Subcutaneous semaglutide injections require precision to maximize therapeutic benefit and minimize injection-site reactions. Unlike intravenous administration, subcutaneous placement allows the medication to absorb gradually into fatty tissue, delivering steady GLP-1 receptor activation. Understanding proper injection technique protects your skin integrity and supports long-term treatment success.

Understanding Semaglutide Injection Site Anatomy

Semaglutide is administered into subcutaneous tissue—the layer of fat directly beneath your skin but above muscle. This fatty layer exists in several areas of your body where blood flow is reliable but injection discomfort is minimal. The subcutaneous route allows the medication to release slowly into your bloodstream over several days, maintaining stable GLP-1 receptor occupancy throughout your treatment cycle.

Body composition affects injection site selection. Patients with adequate subcutaneous fat have more injection options and typically experience less muscle contact during needle insertion. PlexusDx compounded semaglutide is designed for subcutaneous administration, and proper site selection directly impacts your injection experience and medication efficacy.

Approved Semaglutide Injection Sites for Weekly Dosing

The abdomen is the most common semaglutide injection location, offering accessible subcutaneous fat and minimal muscle proximity. Select an area at least two inches below your belly button and at least two inches to the side of your navel to avoid sensitive tissue. The lower abdomen typically has thicker subcutaneous fat, reducing needle contact with underlying structures and improving injection comfort.

The upper arm outer surface provides an alternative site with reliable subcutaneous depth. Pinch the skin and fat between your thumb and forefinger, then inject at a 45-degree angle into the lifted fold. This location works well for patients who prefer variety or experience abdominal sensitivity. The thigh's outer surface, from hip to knee, offers additional rotation options with adequate subcutaneous tissue for safe needle placement at a 90-degree angle.

Injection Technique and Needle Angle Guidelines

Semaglutide injections use short needles (typically 29–31 gauge) that require proper angle positioning for safe subcutaneous placement. A 90-degree angle (perpendicular to skin) works best for areas with thicker subcutaneous fat like the abdomen. For thinner-skinned areas like the arm or thigh, a 45-degree angle reduces the risk of accidentally reaching deeper muscle tissue while ensuring the needle penetrates the subcutaneous layer completely.

Before injecting, clean your injection site with an alcohol pad and allow it to air-dry completely—injecting into wet skin can reduce medication absorption and increase discomfort. Pinch a fold of skin and fat, insert the needle smoothly in one continuous motion, and inject the medication at a steady pace. After injection, withdraw the needle at the same angle you inserted it, release the pinched skin, and apply gentle pressure with a dry cotton ball for five seconds to minimize bleeding and bruising.

Rotating Injection Sites to Prevent Lipohypertrophy

Repeated injections in the same location can cause lipohypertrophy—enlargement of subcutaneous fat tissue that interferes with medication absorption and increases bruising risk. Systematic rotation prevents this complication and maintains consistent semaglutide delivery week to week. PlexusDx recommends dividing each approved injection site (abdomen, upper arm, thigh) into multiple zones and rotating through different zones each week.

Create a rotation pattern that cycles through at least four distinct locations before returning to the first site. For example, inject in your right abdomen one week, left abdomen the next week, right arm the third week, left arm the fourth week, then repeat. This spacing ensures each injection site has a four-week recovery period, allowing subcutaneous tissue to normalize between uses. Document your injection sites in a simple log or app to avoid repeating locations too frequently and maintain medication absorption efficiency throughout your treatment.

Managing Injection Discomfort and Adverse Reactions

Minor injection-site reactions—redness, mild swelling, or bruising—are common and typically resolve within a few days. Applying ice before injection can numb the area and reduce discomfort; applying heat after injection may reduce post-injection soreness. If bruising occurs, gentle compression and elevation help reabsorption. Avoid massaging the injection site immediately after injection, as this can increase bleeding and bruising.

Lipodystrophy (loss of fat at injection sites) or persistent nodules warrant site rest and consultation with your healthcare provider. PlexusDx supports patients with detailed injection guidance and personalized compounded semaglutide dosing strategies. If you experience severe pain, swelling, or signs of infection (warmth, pus, fever), contact your provider immediately. Most patients find that consistent rotation and proper technique eliminate injection concerns within their first month of treatment.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into muscle instead of fatty tissue?

No. Semaglutide is formulated for subcutaneous administration only. Intramuscular injection can cause unexpected absorption rates, increased discomfort, and potentially harmful medication levels. Always inject into the subcutaneous fat layer beneath your skin, using proper angle and site selection to avoid muscle contact.

How often should I rotate my semaglutide injection sites?

Rotate to a new location each week. If you inject every seven days, use a four-site rotation pattern (right abdomen, left abdomen, right arm, left arm) to give each site four weeks of recovery. This prevents lipohypertrophy, maintains consistent medication absorption, and reduces injection discomfort over time.

What if I have very little subcutaneous fat in my abdomen?

The upper thigh outer surface often has adequate subcutaneous depth even in lean patients. Use a 45-degree angle and pinch the skin fold to ensure needle placement in fatty tissue, not muscle. If all standard sites feel risky, discuss alternative injection techniques with your healthcare provider.

Is PlexusDx semaglutide injection available in all 50 states?

Yes. PlexusDx compounded semaglutide injections are available nationwide without insurance requirements. Starting at $189/month from licensed 503A compounding pharmacies, the medication is HSA/FSA eligible and includes detailed patient guidance on injection technique and site rotation.

Can genetic factors affect how my body responds to semaglutide injection sites?

Yes. The PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R and FTO genes that influence fat metabolism and medication response. Understanding your genetic profile helps optimize injection site selection and anticipate individual absorption patterns, available for $99 after your first month of treatment.

What should I do if I experience bruising or swelling after injection?

Minor bruising is normal and typically resolves within days. Apply ice before injection to numb the area, and gentle heat after to reduce soreness. Ensure you're rotating sites every week and using proper needle angles. If swelling persists or worsens, or if you see signs of infection, contact your healthcare provider.

Related Reading

• Injection Wegovy
• Mounjaro Injection Sites
• Wegovy Shot
• Wegovy Injection Site

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.